These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 39397064)
1. Identifying risk factors for recurrent multidrug resistant tuberculosis based on patient's record data from 2016 to 2021: retrospective study. Wotale TW; Lelisho ME; Negasa BW; Tareke SA; Gobena WE; Amesa EG Sci Rep; 2024 Oct; 14(1):23912. PubMed ID: 39397064 [TBL] [Abstract][Full Text] [Related]
2. Modeling Time to Death of Patients with Multidrug-Resistant Tuberculosis at Saint Peter's Specialized Hospital. Wotale TW; Terefe AN; Fufa JA J Res Health Sci; 2021 May; 21(2):e00513. PubMed ID: 34465635 [TBL] [Abstract][Full Text] [Related]
3. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study. Abebe M; Atnafu A; Tilahun M; Sero N; Neway S; Alemu M; Tesfaye G; Mihret A; Bobosha K; Wan C PLoS One; 2024; 19(5):e0304507. PubMed ID: 38820260 [TBL] [Abstract][Full Text] [Related]
4. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. Hirpa S; Medhin G; Girma B; Melese M; Mekonen A; Suarez P; Ameni G BMC Public Health; 2013 Aug; 13():782. PubMed ID: 23981845 [TBL] [Abstract][Full Text] [Related]
5. Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia. Dessalegn M; Daniel E; Behailu S; Wagnew M; Nyagero J Pan Afr Med J; 2016; 25(Suppl 2):5. PubMed ID: 28439330 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. Desissa F; Workineh T; Beyene T BMC Public Health; 2018 Apr; 18(1):422. PubMed ID: 29606112 [TBL] [Abstract][Full Text] [Related]
7. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118 [TBL] [Abstract][Full Text] [Related]
8. Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients. Esayas Lelisho M; Akessa GM; Kifle Demissie D; Fikadu Yermosa S; Andargie SA; Tareke SA; Pandey D J Gastrointest Cancer; 2023 Mar; 54(1):104-116. PubMed ID: 35064523 [TBL] [Abstract][Full Text] [Related]
9. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia. Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154 [TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. Demile B; Zenebu A; Shewaye H; Xia S; Guadie A BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354 [TBL] [Abstract][Full Text] [Related]
11. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study. Admassu F; Abera E; Gizachew A; Sedoro T; Gari T BMJ Open; 2023 Jan; 13(1):e061836. PubMed ID: 36639214 [TBL] [Abstract][Full Text] [Related]
12. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia. Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia. Abate D; Taye B; Abseno M; Biadgilign S BMC Res Notes; 2012 Aug; 5():462. PubMed ID: 22929063 [TBL] [Abstract][Full Text] [Related]
15. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076 [TBL] [Abstract][Full Text] [Related]
16. Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia. Limenih YA; Workie DL BMC Public Health; 2019 Feb; 19(1):165. PubMed ID: 30732601 [TBL] [Abstract][Full Text] [Related]
18. Psychological distress and its effect on tuberculosis treatment outcomes in Ethiopia. Tola HH; Shojaeizadeh D; Garmaroudi G; Tol A; Yekaninejad MS; Ejeta LT; Kebede A; Karimi M; Kassa D Glob Health Action; 2015; 8():29019. PubMed ID: 26610316 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Mulu W; Mekonnen D; Yimer M; Admassu A; Abera B Afr Health Sci; 2015 Jun; 15(2):368-77. PubMed ID: 26124781 [TBL] [Abstract][Full Text] [Related]
20. Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis. Cai X; Xu X; He G; Jiang X; Wu L BMC Infect Dis; 2024 Aug; 24(1):807. PubMed ID: 39123148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]